Home > Insider Trading > Filing (0001209191-22-030286)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082038	Durect Corp	DRRX	Pharmaceutical Preparations (2834)	943297098

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614780	M Gail Farfel	C/O Durect Corporation 10260 Bubb Road Cupertino CA 95014		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-16	25,300	$0.39	70,089	No	4	P	Direct
Common Stock	Acquisiton	2022-05-18	29,911	$0.41	100,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.3734 to $0.4150 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.4023 to $0.4136 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.